Key result
Arrhythmogenic right ventricular cardiomyopathy is an increasingly recognized cause of sudden cardiac death in young athletes, though optimal treatment remains unclear.
Answers are grounded in this paper and cite their sources.
ARVC is an increasingly recognized cause of sudden cardiac death in young people, with unclear optimal treatment strategies.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an increasingly recognized cause of ventricular tachycardia and sudden cardiac death in young people, notably young athletes. The best treatment is not clear, although options include antiarrhythmic drugs, radiofrequency ablation, and implantable defibrillators.
No takes yet. Share an insight, caveat, or question.
McRae et al. (2001) studied this question. Arrhythmogenic right ventricular cardiomyopathy is an increasingly recognized cause of sudden cardiac death in young athletes, though optimal treatment remains unclear.
Synapse has enriched 10 related papers. Consider them for comparative context: